LAEVOMYCETIN

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

Powder for injection intravenous adm. intramuscular adm.

The image of the packaging corresponds to the packaging currently registered with the regulatory authorities of Ukraine.

In case of any discrepancies, please contact us at tel. +380 44 490 75 22

  • Laevomycetin is indicated for typhoid fever, paratyphoid fever, generalized forms of salmonellosis, dysentery, brucellosis, tularemia, meningitis, spotted fever and other ricketsioses, trachoma. Infectious processes due to laevomycetin-susceptible pathogens when other chemotherapeutic preparations are ineffective or their administration is not feasible.
  • 1 vial contains 0.5 or 1.0 g of sterile laevomycetin succinate sodium salt equivalent to laevomycetin.

Buy from partners

From 64 uah

Order

Check at pharmacy

Order

Order

From 64 uah

Order
or order from partners

Legal Agreement for Information Access

This section contains information intended for healthcare institutions and professionals (hereinafter "licensed medical specialists") and includes specialized professional information about pharmaceuticals, including prescription medications. This information encompasses details such as drug names, descriptions, usage instructions, potential side effects, contraindications, and other professional information. The information is for informational purposes only and should not be used as a guide for self-diagnosis or treatment. Medication should be used only as directed by a physician, as self-treatment can be harmful to health.

Do you confirm that you have reviewed this restriction on information access and are a healthcare specialist?

No

Дякуємо за звернення!

Ваша форма успішно відправлена. Якщо у вас виникли додаткові питання, будь ласка, заповніть форму на сайті або зателефонуйте нам

Pharmacovigilance

If you have any information about an adverse reaction and/or lack of efficacy of an Arterium Corporation drug, please fill out the form: